| DIRECT COMPETITOR COMPARISON | |
| BIIB | Pvt1 | BMY | Pvt2 | Industry | | Market Cap: | 13.70B | N/A | 49.84B | N/A | 97.43M | | Employees: | 4,700 | N/A | 35,000 | N/A | 65 | | Qtrly Rev Growth (yoy): | 2.50% | N/A | 4.40% | N/A | 19.70% | | Revenue (ttm): | 4.32B | N/A | 21.14B | N/A | 14.05M | | Gross Margin (ttm): | 91.12% | N/A | 72.39% | N/A | 63.92% | | EBITDA (ttm): | 1.68B | N/A | 6.32B | N/A | -12.30M | | Oper Margins (ttm): | 28.43% | N/A | 26.65% | N/A | -124.89% | | Net Income (ttm): | 869.75M | N/A | 3.79B | N/A | N/A | | EPS (ttm): | 2.988 | N/A | 1.933 | N/A | -0.32 | | P/E (ttm): | 15.86 | N/A | 13.02 | N/A | 16.41 | | PEG (5 yr expected): | 1.38 | N/A | 2.48 | N/A | 1.31 | | P/S (ttm): | 3.17 | N/A | 2.36 | N/A | 9.54 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 56.80 | 0.00% | 57.49B | 12.39 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 47.38 | 0.00% | 13.70B | 15.86 | | Genzyme Corp. | GENZ | 50.38 | 0.00% | 13.37B | 28.72 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.96 | 0.00% | 42.26B | 18.16 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 50.18 | 0.00% | 8.95B | 1024.08 | | Teva Pharmaceutical Industries Limited | TEVA | 53.27 | 0.00% | 46.93B | 48.74 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 37.05 | 0.00% | 3.93B | 19.10 | | Barr Pharmaceuticals, Inc. | Private - View Profile | | King Pharmaceuticals Inc. | KG | 12.08 | 0.00% | 3.00B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 18.30 | 0.00% | 5.59B | 112.27 | | Pfizer Inc. | PFE | 18.31 | 0.00% | 147.75B | 15.21 | | Johnson & Johnson | JNJ | 63.18 | 0.00% | 174.32B | 13.80 | | GlaxoSmithKline plc | GSK | 42.28 | 0.00% | 107.18B | 13.30 | | Sanofi-Aventis | SNY | 38.63 | 0.00% | 100.87B | N/A |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Novartis AG | NVS | 55.30 | 0.00% | 125.60B | 16.56 | | RHHBY.PK | 41.45 | 0.00% | N/A | N/A | | AstraZeneca plc | AZN | 45.25 | 0.00% | 65.61B | 9.09 | | Abbott Laboratories | ABT | 54.24 | 0.00% | 83.90B | 14.70 | | Bristol-Myers Squibb Co. | BMY | 25.16 | 0.00% | 49.84B | 13.02 |
|
| NEWS ON DIRECT COMPETITORS | |
|
|
|